| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Over the last 12 months, insiders at Regencell Bioscience Holdings Limited have bought $0 and sold $0 worth of Regencell Bioscience Holdings Limited stock.
On average, over the past 5 years, insiders at Regencell Bioscience Holdings Limited have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $369,000 was made by BELL THOMAS D JR (director) on 2017‑08‑29.
| 2017-08-29 | BELL THOMAS D JR | director | 25,000 0.4487% | $14.76 | $369,000 | |||
| 2017-08-25 | KAPLAN STEPHEN A | director | 10,000 0.1808% | $14.87 | $148,700 | |||
| 2017-08-24 | Ownby David | EVP, CFO and Treasurer | 7,500 0.128% | $14.04 | $105,300 | |||
| 2017-03-09 | Sale | BRANDOW PETER B | EVP, General Counsel, Sec. | 20,233 0.5535% | $22.50 | $455,243 | ||
| 2017-03-09 | Sale | DUNN GREGORY W | President and COO | 26,050 0.7016% | $22.15 | $577,008 | ||
| 2016-11-23 | Sale | ANSCHUTZ PHILIP F | 10 percent owner | 13M – | $22.95 | $298.35M | ||
| 2016-09-07 | Sale | DUNN GREGORY W | President and COO | 30,765 0.8136% | $21.75 | $669,139 | ||
| 2016-08-08 | Sale | ANSCHUTZ PHILIP F | 10 percent owner | 13M – | $21.60 | $280.8M | ||
| 2016-06-29 | Sale | BRANDOW PETER B | EVP, General Counsel, Sec. | 49,024 1.2822% | $21.51 | $1.05M | ||
| 2016-06-15 | Sale | DUNN GREGORY W | President and COO | 25,000 0.6165% | $20.28 | $507,000 | ||
| 2016-03-15 | Sale | MILES AMY E | CEO | 28,201 0.7139% | $20.82 | $587,145 | ||
| 2016-03-14 | Sale | MILES AMY E | CEO | 75,000 1.9352% | $21.22 | $1.59M | ||
| 2015-05-19 | Sale | DUNN GREGORY W | President and COO | 19,000 0.4944% | $21.40 | $406,600 | ||
| 2015-03-13 | Weigand Nestor R Jr | director | 88.14 0.0024% | $22.54 | $1,987 | |||
| 2015-02-18 | Sale | YEMENIDJIAN ALEX | director | 58,475 1.6616% | $23.37 | $1.37M | ||
| 2014-06-05 | Sale | DUNN GREGORY W | President and COO | 25,000 0.6107% | $20.09 | $502,250 | ||
| 2011-02-28 | Sale | DUNN GREGORY W | President and COO | 90,000 1.6415% | $15.00 | $1.35M | ||
| 2010-07-12 | Sale | ANSCHUTZ PHILIP F | 10 percent owner | 7.3M – | $13.70 | $100M | ||
| 2010-07-12 | ANSCHUTZ PHILIP F | 10 percent owner | 7.3M – | $13.70 | $100M | |||
| 2009-11-23 | Weigand Nestor R Jr | director | 2,000 0.0332% | $13.64 | $27,280 |
| Increased Positions | 11 | +50% | 48,946 | +7.72% |
| Decreased Positions | 10 | -45.45% | 134,336 | -21.19% |
| New Positions | 7 | New | 19,117 | New |
| Sold Out Positions | 6 | Sold Out | 62,138 | Sold Out |
| Total Postitions | 23 | +4.55% | 548,421 | -13.47% |
| Geode Capital Management, Llc | $8,626.00 | 0.09% | 419,970 | +28,904 | +7.39% | 2025-09-30 |
| Squarepoint Ops Llc | $1,053.00 | 0.01% | 51,249 | -48,594 | -48.67% | 2025-09-30 |
| Discovery Capital Management, Llc / Ct | $948.00 | 0.01% | 46,166 | +46,166 | New | 2025-09-30 |
| Xtx Topco Ltd | $796.00 | 0.01% | 38,735 | +38,735 | New | 2025-09-30 |
| Morgan Stanley | $777.00 | 0.01% | 37,842 | +4,822 | +14.6% | 2025-09-30 |
| Vident Advisory, Llc | $371.00 | <0.01% | 18,068 | +18,068 | New | 2025-09-30 |
| Jane Street Group, Llc | $218.00 | <0.01% | 10,616 | +10,616 | New | 2025-09-30 |
| Blackrock, Inc. | $100.00 | <0.01% | 4,865 | -3,724 | -43.36% | 2025-09-30 |
| Bnp Paribas Financial Markets | $96.00 | <0.01% | 4,682 | -40,368 | -89.61% | 2025-09-30 |
| Ubs Group Ag | $8.00 | 0% | 380 | -37,147 | -98.99% | 2025-09-30 |